Results

eNauka >  Results >  Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3trial
Title: Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3trial
Authors Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S  ; ...; (broj, koautora 21)
Issue Date: 2023
Publication: LANCET HAEMATOLOGY
ISSN: 2352-3026 Lancet Haematology Search Idenfier
Type: Article
Collation: vol. 10 br. 10 str. e813-e824
DOI: 10.1016/S2352-3026(23)00218-1
WoS-ID: 001088889800001
Scopus-ID: 2-s2.0-85172680628
URI: https://enauka.gov.rs/handle/123456789/934853
Project: European Myeloma Network
Janssen Research Development
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21aM21a

6
SCOPUSTM
6
WEB OF SCIENCETM
Altmetric
Dimensions

Find the DOI

Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.